VR Logo

Astrazeneca Pharma India Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1979

Chairman: Narayan K Seshadri

Managing Director: Gagandeep Singh Bedi

Group: Astrazeneca Pharma India - MNC

Listing: NSE: ASTRAZEN, BSE: 506820

Headquarters: Bengaluru, Karnataka

Website: www.astrazenecaindia.com

Key Facts

Market cap: R 9,815.75 Cr

Revenue (TTM): R 821.82 Cr

Earnings (TTM): R 81.25 Cr

Cash: R 252.52 Cr

Total Debt: R 0.00 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 1,885.00 - 4,970.00

Face value: R2.00

Shares outstanding: 2,50,00,000

10 Years Aggregate:

  • CFO: 296.96 Cr
  • EBITDA: 332.84 Cr
  • Net Profit: 150.89 Cr

Stock Performance

Time Period Astrazeneca Pharma India S&P BSE Healthcare S&P BSE Mid Cap
YTD-14.940.936.77
1 month-9.601.907.61
3 months-8.9210.6829.65
1 Year57.5356.2222.65
3 Years51.8913.722.54
5 Years27.817.2613.79
10 Years12.5012.8210.31
As on 20-Jan-2021
Year Astrazeneca Pharma India S&P BSE Mid Cap S&P BSE Healthcare
202076.3919.8761.45
201981.26-3.05-3.55
201824.22-13.31-5.89
201726.0048.130.49
2016-26.417.97-12.88
201543.317.4315.06
20142.9454.6947.43